Text Size

Muscle Strength and Functional Autonomy of Elderly Women

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Euro-American Network of Human Kinetics
ClinicalTrials.gov Identifier:
NCT01553396
First received: March 7, 2012
Last updated: March 13, 2012
Last verified: March 2012
History of Changes

March 7, 2012
March 13, 2012
January 2009
February 2009   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01553396 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Muscle Strength and Functional Autonomy of Elderly Women
Muscle Strength and Functional Autonomy of Normo-IGF-1 Elderly Women With Skeletal Muscle Dysfunctions

This study shows an evaluation of the correlation between the muscle strength levels and functional autonomy of elderly women.

The aim of this study was to evaluate the correlation between the muscle strength levels and functional autonomy of elderly women with impaired muscle-skeletal system depending on the normal IGF-1 level. The target-population was composed by elderly women aged between 60 and 75 years (age: 67.79 ± 5.11 years, BMI: 28.01 ± 5.4), residents of an asylum, with IGF-1 levels within the normal values for the age (normo-IGF-1). Evaluations of the muscle strength (1-RM test) and the functional autonomy (GDLAM Protocol) in the performance of activities of daily living (ADL), and a measurement of basal serum levels of IGF-1 (Chemiluminescence method) were performed.
Observational
Observational Model: Case-Only
Not Provided
Retention:   Samples Without DNA
Description:

Whole blood
Non-Probability Sample

The population consists of 123 elderly women residents of São Lucas shelter, located in Cacimba Velha, Teresina-PI, Brazil. The sample consists of 35 elderly women. The elderly participants in the study signed a written informed consent.
Muscle, Ligament and Fascia Disorders
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
35
April 2009
February 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • present a muscle-skeletal dysfunction, such as osteoporosis, arthritis, tendinitis, but being able to perform their ADL without help from others;
  • did not practice physical activity for at least 12 months;
  • provide a normal IGF-1 level for their age;

Exclusion Criteria:

  • elderly women unfit to perform the strength and functional autonomy tests for the medical assessment;
Female
60 Years to 75 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01553396
0165/2008
No
Euro-American Network of Human Kinetics
Euro-American Network of Human Kinetics
Not Provided
Study Chair: Estélio HM Dantas, DSc University Castelo Branco (Rio de Janeiro, Brazil)
Euro-American Network of Human Kinetics
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP